Navigation Links
Diopsys, Inc. Launches New Website for Doctors and Patients, www.Diopsys.com
Date:5/12/2011

PINE BROOK, N.J., May 12, 2011 /PRNewswire/ -- Diopsys, Inc. launched its new website – www.diopsys.com - that showcases the company's growing product line and vision for the future. The new website features expanded product information, educational resources for physicians and patients, as well as improved navigation and search capabilities. The re-designed site was initiated to address the growing need of customers and patients to have access to the most up-to-date clinical information.

The site's new homepage has a clean, clear design that enables visitors to quickly find the section of the site that most applies to them. The "News and Events" section gives visitors a quick look at what is going on with Diopsys' core technology, Visual Evoked Potential (VEP), the meetings Diopsys is attending, and current vision testing news. "We wanted to create a more accessible, user-friendly site for customers and patients to find the information they were looking for quickly, but also introduce them to additional knowledge on our vision testing technology," says Caitlin Ryan-Wise, Marketing Manager for Diopsys.

One of the most clinically beneficial sections of Diopsys.com is the "Case Studies" section.  Optometrists, Ophthalmologists and Pediatricians each have their own area to review patient case studies that their peers have contributed.  This gives physicians a chance to communicate with one another on how they are using Diopsys VEP vision testing systems to enhance their patient care.

"Additionally," Ryan-Wise says, "with the most recent launch of the Diopsys® NOVA-DN VEP Vision Testing System for optic nerve disorders including glaucoma, we have had a significant increase in optometrists and ophthalmologists looking for information on our products.  We felt now was a great time to re-vamp the site for prospective customers and investors."

Diopsys, Inc. (http://www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care.  The company specializes in the development and marketing of patient-friendly, non-invasive diagnostic vision testing equipment.  Diopsys has developed and markets the patented Enfant® Pediatric Vision Testing System, a device used by pediatricians to test for visual deficits, including amblyopia, in children as young as six months of age. Diopsys also developed and markets the Diopsys® NOVA-DT (Diagnostic & Tracking), Diopsys® NOVA-TR (Transient Response) and Diopsys® NOVA-DN (Diseases of the Optic Nerve)  Vision Testing Systems utilized by ophthalmologists and optometrists for the detection, diagnosis and treatment of vision disorders.


'/>"/>
SOURCE Diopsys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula
2. Pierrel Research USA Launches Orabloc™ a New Purer Articaine
3. Life Technologies Launches 7500 Fast Dx Real-Time PCR Instrument and 3500 Dx Series Genetic Analyzer in Japan
4. BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
5. Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe
6. Bacterin International Holdings Launches Third Biologic Scaffold
7. Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians
8. Remedi SeniorCare® Launches Electronic Order Entry Capability as Part of the My Remedi® Suite of Online Tools
9. Nonin Medical Launches Low Power Xpod®, Model 3012LP, OEM Pulse Oximeter Globally
10. Netsmart Technologies Launches Exchange for Customers to Share Applications and Information
11. Watson Launches Generic Concerta®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/13/2017)... 2017 RK Logistics Group, Inc. was awarded ... its Fremont, CA headquarters facility where ... and San Jose for hi-tech, pharmaceutical ... , with its Fremont Innovation District, is excited to ... powerful resource to the hundreds of biotech, pharma and biomed ...
(Date:7/12/2017)... -- CarpalAID is a revolutionary new product that relieves painful carpal ... tunnel syndrome affects more than 8 million people a year. Women ... The common methods of treating CTS are painful surgery, the use ... gloves. ... CarpalAID is a clear patch worn on the palm of the ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... In the first prospective ACL reconstruction ... Outcome Network (MOON) demonstrated that patients could perform sports-related functions and maintain a ... over time. The study, presented today at the American Orthopaedic Society for ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... rates are on the rise, say researchers presenting their work at the ... Canada. , “The combination of evaluating the patterns of change in concussion symptom ...
(Date:7/20/2017)... Richmond, Va. (PRWEB) , ... July 20, 2017 , ... ... Daniel McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief ... of Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
Breaking Medicine News(10 mins):